(Press-News.org) Contact information: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Scientists solve 40-year mystery of how sodium controls opioid brain signaling
The findings pave way for new therapies for treating pain and mood disorders
LA JOLLA, CA—January 12, 2014—Scientists have discovered how the element sodium influences the signaling of a major class of brain cell receptors, known as opioid receptors. The discovery, from The Scripps Research Institute (TSRI) and the University of North Carolina (UNC), suggests new therapeutic approaches to a host of brain-related medical conditions.
"It opens the door to understanding opioid related drugs for treating pain and mood disorders, among others," said lead author Dr. Gustavo Fenalti, a postdoctoral fellow in the laboratory of Professor Raymond C. Stevens of TSRI's Department of Integrative Structural and Computational Biology.
"This discovery has helped us decipher a 40-year-old mystery about sodium's control of opioid receptors," said Stevens, who was senior author of the paper with UNC pharmacologist Professor Bryan Roth. "It is amazing how sodium sits right in the middle of the receptor as a co-factor or allosteric modulator."
The findings appear in an advanced online publication in the journal Nature on January 12, 2014.
A Sharper Image
The researchers revealed the basis for sodium's effect on signaling with a high-resolution 3-D view of an opioid receptor's atomic structure. Opioid receptors are activated by peptide neurotransmitters (endorphins, dynorphins and enkephalins) in the brain. They can also be activated by plant-derived and synthetic drugs that mimic these peptides: among them morphine, codeine, oxycodone and heroin.
Despite these receptors' crucial importance in health and disease, including pain disorders and addictions, scientists have only begun to understand in detail how they work. Opioid receptors are inherently flimsy and fragile when produced in isolation, and thus have been hard to study using X-ray crystallography, the usual structure-mapping method for large proteins.
In recent years, the Stevens laboratory has helped pioneer the structure determination of G protein-coupled receptors. Although the first crystallographic structures of opioid receptors were determined in 2012, these structural models weren't fine-grained enough to solve a lingering mystery, particularly for the human delta opioid receptor.
That mystery concerned the role of sodium. The element is perhaps best known to biologists as one of the key "electrolytes" needed for the basic workings of cells. In the early 1970s, researchers in the laboratory of neuroscientist Solomon Snyder at Johns Hopkins University, who had helped discover opioid receptors, found evidence that sodium ions also act as a kind of switch on opioid receptor signaling. They noted that at concentrations normally found in brain fluid, these ions reduced the ability of opioid peptides and drugs like morphine to interact with opioid receptors.
How sodium could exert this indirect ("allosteric") effect on opioid receptor activity was unclear—and has remained an unsolved puzzle for decades. Now that scientists have discovered the mechanism of sodium's effect, then in principle they can exploit it to develop better opioid-receptor-targeting drugs.
A Switch Controlling Pain, Depression and Mood Disorders
For the new study, the team constructed a novel, fusion-protein-stabilized version of one of the main opioid receptors in the human brain, known as the delta opioid receptor, and managed to form crystals of it for X-ray crystallography. The latter revealed the receptor's 3-D atomic structure to a resolution of 1.8 Angstroms (180 trillionths of a meter)—the sharpest picture yet of an opioid receptor.
"Such a high resolution is really necessary to be able to understand in detail how the receptor works," said Stevens.
The analysis yielded several key details of opioid receptor structure and function, most importantly the details of the "allosteric sodium site," where a sodium ion can slip in and modulate receptor activity.
The team was able to identify the crucial amino acids that hold the sodium ion in place and transmit its signal-modulating effect. "We found that the presence of the sodium ion holds the receptor protein in a shape that gives it a different affinity for its corresponding neurotransmitter peptides," Fenalti said.
With the structural data in hand, the researchers designed new versions of the receptor, in which key sodium-site amino-acids were mutated, to see how this would affect receptor signaling. Co-lead author Research Associate Patrick M. Giguere and colleagues in Roth's Laboratory at UNC, which has long collaborated with the Stevens laboratory, tested these mutant receptors and found that certain amino-acid changes cause radical shifts in the receptor's normal signaling response.
The most interesting shifts involved a little-understood secondary or "alternative" signaling route, known as the beta-arrestin pathway, whose activity can have different effects depending on the type of brain cell involved. Some drugs that normally bind to the delta opioid receptor and have little or no effect on the beta-arrestin pathway turned out to strongly activate this pathway in a few of these mutant receptors.
In practical terms, these findings suggests a number of ways in which new drugs could target these receptors—and not only delta opioid receptors but also the other two "classical" opioid receptors, mu and kappa opioid receptors. "The sodium site architecture and the way it works seems essentially the same for all three of these opioid receptor types," said Fenalti.
INFORMATION:
Other co-authors of the study, "Molecular control of Delta-opioid receptor signaling," were Assistant Professor Vsevolod Katritch, former Staff Scientist Aaron A. Thompson and Associate Professor Vadim Cherezov of TSRI, and Assistant Scientific Director Xi-Ping Huang of the University of North Carolina.
The research was funded in part by the National Institutes of Health (grants P50 GM073197, U54 GM094618, R01 DA017204), the National Cancer Institute (Y1-CO-1020), the National Institute for General Medical Sciences (Y1-GM-1104) and the National Institute of Mental Health Psychoactive Drug Screening Program.
Scientists solve 40-year mystery of how sodium controls opioid brain signaling
The findings pave way for new therapies for treating pain and mood disorders
2014-01-13
ELSE PRESS RELEASES FROM THIS DATE:
It's all coming back to me now: Researchers find caffeine enhances memory
2014-01-13
It's all coming back to me now: Researchers find caffeine enhances memory
For some, it's the tradition of steeping tealeaves to brew the perfect cup of tea. For others, it's the morning shuffle to a coffee maker for a hot jolt of java. Then there are those who ...
Mutation discovery may improve treatment for rare brain tumor type
2014-01-13
Mutation discovery may improve treatment for rare brain tumor type
Study findings could lead to targeted therapies for hard-to-treat craniopharyngiomas
BOSTON, Jan. 12, 2014 -- Scientists have identified a mutated gene that causes a type of tenacious, ...
Non-coding DNA implicated in type 2 diabetes
2014-01-13
Non-coding DNA implicated in type 2 diabetes
Variations in non-coding sections of the genome might be important contributors to type 2 diabetes risk, according to a new study.
DNA sequences that don't encode proteins were once dismissed as "junk DNA", ...
Multi-institutional team finds targetable mutation in rare brain tumor
2014-01-13
Multi-institutional team finds targetable mutation in rare brain tumor
BRAF mutation associated with other cancers appears to drive papillary craniopharyngiomas
A team led by investigators from Massachusetts General Hospital (MGH), Brigham and Women's ...
Designer 'swiss-army-knife' molecule captures RNA in single cells in their natural tissue environment
2014-01-13
Designer 'swiss-army-knife' molecule captures RNA in single cells in their natural tissue environment
Findings allow for better understanding of how tissue microenvironment affects gene expression in healthy and diseased cells
PHILADELPHIA ...
Ultrasound directed to the human brain can boost sensory performance
2014-01-13
Ultrasound directed to the human brain can boost sensory performance
Virginia Tech Carilion Research Institute scientists say ultrasound ranks with leading neuromodulation techniques in achieving spatial resolution
Whales, bats, and even praying mantises use ultrasound as a sensory ...
Tweaking MRI to track creatine may spot heart problems earlier, Penn Medicine study suggests
2014-01-13
Tweaking MRI to track creatine may spot heart problems earlier, Penn Medicine study suggests
Measuring creatine levels with MRI has benefits over contrast-enhanced MRI and MRS
PHILADELPHIA— A new MRI method to map creatine at higher ...
Study: At-home test can spot early Alzheimer's
2014-01-13
Study: At-home test can spot early Alzheimer's
Finding symptoms early is crucial to treatment, at-home paper test can help
COLUMBUS, Ohio – The Self-Administered Gerocognitive Examination (SAGE test), which takes less than 15 minutes ...
School drug tests don't work, but 'positive climate' might
2014-01-13
School drug tests don't work, but 'positive climate' might
PISCATAWAY, NJ – School drug testing does not deter teenagers from smoking marijuana, but creating a "positive school climate" just might, according to research reported in the ...
Brief mental training sessions have long-lasting benefits for seniors' cognition and everyday function
2014-01-13
Brief mental training sessions have long-lasting benefits for seniors' cognition and everyday function
Older adults who received as few as 10 sessions of mental (cognitive) training showed improvements in reasoning ability and speed-of-processing when compared with untrained ...
LAST 30 PRESS RELEASES:
ACP’s Best Practice Advice addresses use of cannabis, cannabinoids for chronic noncancer pain
Beyond photorespiration: A systematic approach to unlocking enhanced plant productivity
How a small number of mutations can fuel outbreaks of western equine encephalitis virus
Exposure to wildfire smoke linked with worsening mental health conditions
Research uncovers hidden spread of one of the most common hospital-associated infections
Many older adults send their doctors portal messages, but who pays?
Fine particulate matter from 2020 California wildfires and mental health–related emergency department visits
Gender inequity in institutional leadership roles in US academic medical centers
Pancreatic cells ‘remember’ epigenetic precancerous marks without genetic sequence mutations
Rare combination of ovarian tumors found in one patient
AI-driven clinical recommendations may aid physician decision making to improve quality of care
Artificial intelligence has potential to aid physician decisions during virtual urgent care
ACP and Annals of Internal Medicine present breaking scientific news at ACP’s Internal Medicine Meeting 2025
New study reveals polymers with flawed fillers boost heat transfer in plastics
Signs identified that precede sudden arrhythmic death syndrome in young people
Discovery of bacteria's defence against viruses becomes a piece of the puzzle against resistance
Pre-eclampsia is associated with earlier onset and higher incidence of cardiovascular risk factors
Warwick astronomers discover doomed pair of spiralling stars on our cosmic doorstep
Soil conditions significantly increase rainfall in world’s megastorm hotspots
NK cells complexed with bispecific antibody yield high response rates in patients with lymphoma
Planetary health diet and mediterranean diet associated with similar survival and sustainability benefits
Singapore launches national standard to validate antimicrobial disinfectant products
Molecular stool test could improve detection of tuberculosis in adults with HIV
Suspected fibrocartilaginous embolus in Asian small-clawed otter (Aonyx cinereus)
Enhancing heat transfer using the turbulent flow of viscoelastic fluids
Exercise as an anti-ageing intervention to avoid detrimental impact of mental fatigue
UMass Amherst Nursing Professor Emerita honored as ‘Living Legend’
New guidelines aim to improve cystic fibrosis screening
Picky eaters by day, buffet by night: Butterfly, moth diets sync to plant aromas
Pennington Biomedical’s Dr. Leanne Redman honored with the E. V. McCollum Award from the American Society for Nutrition
[Press-News.org] Scientists solve 40-year mystery of how sodium controls opioid brain signalingThe findings pave way for new therapies for treating pain and mood disorders